Terumo Blood and Cell Technologies
Budget
€300 — €0
EP Access
1
accredited persons
Staff
1
1 FTE
EU Grants
None
Mission & Goals
Terumo BCT, a global leader in blood component and cellular technologies, is the only company with the unique combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction coupled with leading technologies in therapeutic apheresis and cell processing. We believe in the potential of blood to do even more for patients than it does today. This belief inspires our innovation and strengthens our collaboration with customers.
EU Legislative Interests
Medical Device Regulation REACH EU Green Deal SoHo Regulation Non-legislative policies on rare diseases, health inequality, blood health
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
MedTech Europe www.medtecheurope.org/ MedPharmPlast www.medpharmplasteurope.org/ Blood Transfusion Association (BTA) https://bloodtransfusionassociation.org/
Commissioner Meetings
No recorded meetings with EU commissioners.